Navidea Biopharmaceuticals, Inc.
(NYSE Amex Equities : NAVB)

( )
NAVB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.10%38.410.9%$1248.28m
JNJJohnson & Johnson -0.44%147.950.7%$870.62m
MRKMerck & Co., Inc. -0.06%80.970.7%$637.23m
ABBVAbbVie, Inc. -0.57%92.391.9%$603.09m
BMYBristol-Myers Squibb Co. 1.30%61.811.0%$599.18m
AZNAstraZeneca Plc -0.07%55.371.2%$573.33m
LLYEli Lilly & Co. 0.07%153.031.1%$425.60m
NVSNovartis AG -0.64%82.380.2%$142.36m
GSKGlaxoSmithKline Plc 0.39%40.950.2%$136.09m
MISTMilestone Pharmaceuticals, Inc. -3.27%9.480.0%$135.86m
OPKOPKO Health, Inc. -3.02%5.4611.2%$129.82m
NVONovo Nordisk A/S -0.02%64.630.1%$69.68m
RGENRepligen Corp. -3.25%147.817.1%$68.38m
PRNBPrincipia Biopharma, Inc. -7.86%84.670.0%$58.39m
SNYSanofi -1.17%50.910.2%$56.54m

Company Profile

Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutic. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.